Table 2 Adjusted results for the outcomes of the participants, mean (SE), ANCOVA
|  | Baseline | 10 Weeks | 14 Weeks | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Measure | SM-FPE + TAU | TAU alone | SM-FPE + TAU | TAU alone | F | p | SM-FPE + TAU | TAU alone | F | p | ||||||
Caregivers | ||||||||||||||||
 Trait anxiety | 46.6 | (1.7) | 49.4 | (1.9) | 42.9 | (1.5) | 46.0 | (1.7) | 1.73 | 0.19 | 41.6 | (1.6) | 44.2 | (1.6) | 1.68 | 0.20 |
 State anxiety | 48.5 | (1.8) | 49.0 | (1.5) | 41.0 | (1.8) | 46.4 | (1.7) | 1.84 | 0.18 | 41.7 | (1.7) | 45.2 | (1.8) | 2.06 | 0.16 |
 K6 | 6.8 | (0.8) | 7.2 | (0.9) | 4.9 | (0.7) | 5.1 | (0.7) | 0.11 | 0.74 | 4.3 | (0.6) | 5.7 | (0.7) | 0.58 | 0.45 |
 J-ZBI_8 | 12.3 | (1.3) | 10.9 | (1.2) | 9.3 | (1.1) | 10.9 | (1.2) | < 0.01 | 0.94 | 9.1 | (1.1) | 9.1 | (1.1) | 0.01 | 0.95 |
 FAS | 46.8 | (4.2) | 46.9 | (3.5) | 36.6 | (3.6) | 45.4 | (3.7) | 0.75 | 0.39 | 37.8 | (3.9) | 42.2 | (3.4) | 0.79 | 0.38 |
 LSS | 35.7 | (6.0) | 35.7 | (0.8) | 34.0 | (0.9) | 35.9 | (1.0) | 0.57 | 0.45 | 34.4 | (1.1) | 35.2 | (1.0) | 0.50 | 0.48 |
Patients | ||||||||||||||||
 GAF | 46.6 | (2.4) | 48.5 | (1.9) | 47.5 | (2.3) | 50.1 | (2.2) | 0.60 | 0.44 | 47.1 | (2.5) | 50.6 | (2.4) | 0.77 | 0.38 |
 Kinds of APs | 1.8 | (0.2) | 1.9 | (0.2) | 1.8 | (0.2) | 1.8 | (0.2) | 0.14 | 0.71 | 1.8 | (0.2) | 1.8 | (0.2) | 0.11 | 0.75 |
 Amount of APs, mg | 810 | (112) | 780 | (96) | 806 | (116) | 760 | (95) | 0.07 | 0.80 | 795 | (116) | 744 | (94) | 0.08 | 0.77 |